Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Sales

IceCure Medical (ICCM) Equity Average (2021 - 2024)

IceCure Medical has reported Equity Average over the past 4 years, most recently at $9.5 million for Q4 2024.

  • For Q4 2024, Equity Average fell 49.28% year-over-year to $9.5 million; the TTM value through Dec 2024 reached $9.5 million, down 49.28%, while the annual FY2025 figure was $8.0 million, 16.32% down from the prior year.
  • Equity Average was $9.5 million for Q4 2024 at IceCure Medical, down from $18.8 million in the prior quarter.
  • Across five years, Equity Average topped out at $26.2 million in Q4 2022 and bottomed at $9.5 million in Q4 2024.
  • The 4-year median for Equity Average is $17.5 million (2021), against an average of $17.7 million.
  • Year-over-year, Equity Average skyrocketed 60.65% in 2022 and then plummeted 49.28% in 2024.
  • Over 4 years, Equity Average stood at $16.3 million in 2021, then surged by 60.65% to $26.2 million in 2022, then fell by 28.25% to $18.8 million in 2023, then tumbled by 49.28% to $9.5 million in 2024.
  • The last three reported values for Equity Average were $9.5 million (Q4 2024), $18.8 million (Q4 2023), and $26.2 million (Q4 2022) per Business Quant data.